Katja Koeppen
Senior Scientist in the Department of Global Computational Biology and Digital Sciences
Dr. Katja Koeppen is a Senior Scientist in the Department of Global Computational Biology and Digital Sciences at Boehringer Ingelheim in Ridgefield, Connecticut. Her focus is on research and drug target discovery in immunology and respiratory diseases. She is currently developing a new gene prioritization algorithm to accelerate the identification of novel drug targets. Dr. Koeppen was originally trained as a biochemist and molecular biologist and obtained her PhD from the University of Tuebingen in Germany. Over 10 years ago, she started transitioning from the wet lab to computational biology during her research on Cystic Fibrosis at Dartmouth College. Dr. Koeppen has extensive experience analyzing complex data sets and teaching these skills to others. She has developed and published several web applications that enable data analysis by scientists without computational skills. She is passionate about harnessing high throughput data to gain a better understanding of disease mechanisms and to identify novel drug targets and treatment options.